Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2003-3-28
pubmed:abstractText
Purine analogs and alkylators are important agents in the treatment of chronic lymphocytic leukemia (CLL). Previously, combinations of fludarabine and chlorambucil were abandoned because of increased toxicity from overlapping myelosuppression and immunosuppression. Of the purine analogs active in CLL, pentostatin may be least myelosuppressive. We hypothesized that combining pentostatin with cyclophosphamide would have less myelotoxicity than combinations using other purine analogs.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0732-183X
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
21
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1278-84
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:12663715-Adult, pubmed-meshheading:12663715-Aged, pubmed-meshheading:12663715-Antibiotics, Antineoplastic, pubmed-meshheading:12663715-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:12663715-Bone Marrow, pubmed-meshheading:12663715-Cyclophosphamide, pubmed-meshheading:12663715-Drug Administration Schedule, pubmed-meshheading:12663715-Drug Resistance, pubmed-meshheading:12663715-Female, pubmed-meshheading:12663715-Humans, pubmed-meshheading:12663715-Immunosuppressive Agents, pubmed-meshheading:12663715-Leukemia, Lymphocytic, Chronic, B-Cell, pubmed-meshheading:12663715-Male, pubmed-meshheading:12663715-Middle Aged, pubmed-meshheading:12663715-Neutropenia, pubmed-meshheading:12663715-Pentostatin, pubmed-meshheading:12663715-Thrombocytopenia, pubmed-meshheading:12663715-Treatment Outcome, pubmed-meshheading:12663715-Vidarabine
pubmed:year
2003
pubmed:articleTitle
Pentostatin and cyclophosphamide: an effective new regimen in previously treated patients with chronic lymphocytic leukemia.
pubmed:affiliation
Leukemia Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, and Cornell University Medical College, New York, NY 10021, USA. weissm@mskcc.org
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't